INDV - CONSENSUS CO - Indivior PLC

This chart shows the market price of Indivior PLC (INDV) fixed at 48.81. The business relies on government programs to combat the opioid crisis and insurance coverage while facing patent challenges. A highly stable backdrop is provided by localization in the US and EU, as well as the humanitarian status of its products. Indivior PLC (INDV) leads in addiction therapy, offering Sublocade long-acting injections that are protected from replication.

Indivior PLC is scaling addiction therapy through government partnerships and medical alliances. The weighted average target from investment houses on GURU.Markets aggregates professional analysts' expectations, filtering out subjective management noise. This indicator measures the business's fundamental value through target price dynamics. The upward trend of the line confirms the company's growing market potential. Such a trajectory serves as a signal for the primary selection of the asset for a portfolio.